業績

{ 83件 }

65回日本甲状腺学会学術集会 研修医・大学院生トラベルグラント 大江 悠希先生

  • 2022
  • 糖尿病・内分泌グループ
  • 受賞

Yuki Oe, Hiroshi Nomoto*, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Akinobu Nakamura, Hideaki Miyoshi, Tatsuya Atsumi.

Letter to the Editor regarding Efficacy of IDegLira versus IDegAsp therapy in patients with type 2 diabetes: A randomized crossover study by isCGM

Adv Ther, in press

IF: 4.070、5-year IF4.549

  • 2022
  • 糖尿病・内分泌グループ
  • 欧文論文/letter

Kenichi Kito, Hiroshi Nomoto, Ichiro Sakuma, Akinobu Nakamura, Kyu Yong Cho, Hiraku Kameda, Aika Miya, Kazuno Omori, Shingo Yanagiya, Takahisa Handa, Shinji Taneda, Jun Takeuchi, So Nagai, Kumiko Yamashita, Yoshio Kurihara, Tatsuya Atsumi, Hideaki Miyoshi Effects of pemafibrate on lipid metabolism in patients with type 2 diabetes and hypertriglyceridemia: a multi-center prospective observational study, the PARM-T2D study Diabetes Res Clin Pract, in press

IF: 8.180、5-year IF6.590

  • 2022
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Ofuji Y, Nomoto H, Miya A, Kameda H, Cho KY, Nakamura A, Miyoshi H, Atsumi T. Urethral injury related peri-urethral abscess as a complication of self-catheterization in an older patient with type 2 diabetes.

Geriatr. Gerontol. Int. in press

IF: 3.387

  • 2022
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告

日本糖尿病協会 ウイリアム・カレン賞 中村 昭伸先生

  • 2022
  • 糖尿病・内分泌グループ
  • 受賞

日本内分泌学会 第5回若手臨床内分泌医奨励賞 Runners-Up賞 中田 健人先生

  • 2022
  • 糖尿病・内分泌グループ
  • 受賞

Yamauchi Y, Nakamura A, Yokota T, Takahashi K, Kawata S, Tsuchida K, Omori K, Nomoto H, Kameda H, Cho KY, Anzai T, Tanaka S, Terauchi Y, Miyoshi H, Atsumi T.

Luseogliflozin preserves the pancreatic beta-cell mass and function in db/db mice by improving mitochondrial function.

Sci Rep, in press.

IF: 4.380

  • 2022
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Aika Miya, Akinobu Nakamura, Isao Yokota, Kyu Yong Cho, Hiraku Kameda, Hiroshi Nomoto, Takahiro Takase, Kazuno Omori, Mayuko Ono, So Nagai, Shinji Taneda, Hideaki Miyoshi, Tatsuya Atsumi The agreement between measured HbA1c and optimized target HbA1c based on the Dementia Assessment Sheet for Community-based Integrated Care System 8-items (DASC-8): A cross-sectional study of elderly patients with diabetes Geriatrics and Gerontology International, in press

IF: 2.730

  • 2022
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Nakamura A.

Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Pancreatic Beta-Cell Mass and Function.

Int J Mol Sci, in press.

IF: 5.924

  • 2022
  • 糖尿病・内分泌グループ
  • 欧文論文/総説

Hiroshi Nomoto, Sho Furusawa, Akinobu Nakamura, Jun Takeuchi, So Nagai, Hiroki Yokoyama, Ichiro Sakuma, Shinji Taneda, Yoshio Kurihara, Shin Aoki, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi, and Hideaki Miyoshi Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes:

protocol for a multi-center, prospective, randomized, open-label, parallel-group comparison study (the SWITCH-SEMA 2 study) BMJ Open, in press

IF: 2.692

  • 2022
  • 糖尿病・内分泌グループ
  • 欧文論文/原著